Center-Authored Papers

Filters: Author is Pavletic, Steven Z  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
W
Williams KM, Chien JW, Gladwin MT, Pavletic SZ.  2009.  Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.. JAMA : the journal of the American Medical Association. 302(3):306-14. Abstract
Williams KM, Cheng G-S, Pusic I, Jagasia M, Burns L, Ho VT, Pidala J, Palmer J, Johnston L, Mayer S et al..  2016.  Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 22(4):710-716. Abstract
U
Urbano-Ispizua A, Pavletic SZ, Flowers ME, Klein JP, Zhang M-J, Carreras J, Montoto S, Perales M-A, Aljurf MD, Akpek G et al..  2015.  The Impact of Graft Versus Host Disease on Relapse Rate in Patients with Lymphoma Depends on the Histological Sub-Type and the Intensity of the Conditioning Regimen.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
S
Shulman HM, Cardona DM, Greenson JK, Hingorani S, Horn T, Huber E, Kreft A, Longerich T, Morton T, Myerson D et al..  2015.  NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(4):589-603. Abstract
Salit RB, Fowler DH, Dean RM, Pavletic SZ, Hakim FT, Steinberg SM, Hardy NT, Sportes C, Gress RE, Bishop MR.  2013.  Host lymphocyte depletion as a strategy to facilitate early full donor chimerism after reduced-intensity allogeneic stem cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 19(10):1509-13. Abstract
R
Ringdén O, Pavletic SZ, Anasetti C, Barrett JA, Wang T, Wang D, Antin JH, Di Bartolomeo P, Bolwell BJ, Bredeson C et al..  2009.  The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.. Blood. 113(13):3110-8. Abstract
P
Pavletic SZ, Vogelsang GB, Lee SJ.  2015.  2014 National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: preface to the series.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(3):387-8.
Palmer JM, Lee SJ, Chai X, Storer BE, Flowers MED, Schultz KR, Inamoto Y, Cutler C, Pidala J, Arora M et al..  2012.  Poor Agreement between Clinician Response Ratings and Calculated Response Measures in Patients with Chronic Graft-versus-Host Disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(11):1649-55. Abstract
Palmer J, Chai X, Pidala J, Inamoto Y, Martin PJ, Storer B, Pusic I, Flowers MED, Arora M, Pavletic SZ et al..  2015.  Predictors of survival, non-relapse mortality and failure-free survival in patients treated for chronic graft-versus-host disease.. Blood. Abstract
Palmer J, Williams K, Inamoto Y, Chai X, Martin PJ, Tomas LS, Cutler C, Weisdorf D, Kurland BF, Carpenter PA et al..  2013.  Pulmonary Symptoms Measured by the National Institutes of Health Lung Score Predict Overall Survival, Nonrelapse Mortality, and Patient-Reported Outcomes In Chronic Graft-Versus-Host Disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
M
Mitchell SA, Jacobsohn D, Thormann Powers KE, Carpenter PA, Flowers MED, Cowen EW, Schubert MM, Turner ML, Lee SJ, Martin PJ et al..  2011.  A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(11):1619-29. Abstract
Martin PJ, Pavletic SZ.  2009.  Biology and management of chronic graft-versus-host disease.. Cancer treatment and research. 144:277-98.
Martin PJ, Lee SJ, Przepiorka D, Horowitz MM, Koreth J, Vogelsang GB, Walker I, Carpenter PA, Griffith LM, Akpek G et al..  2015.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
L
Lee S, Flowers ME, Martin PJ, Carpenter P, Hansen J, Chai X, Kurland B, Storer B, Arai S, Johnston L et al..  2011.  Rationale and design of the chronic GVHD cohort study: improving outcomes assessment in chronic GVHD.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(8):1114-20. Abstract
K
Kharfan-Dabaja MA, Kumar A, Hamadani M, Stilgenbauer S, Ghia P, Anasetti C, Dreger P, Montserrat E, Perales M-A, Alyea EP et al..  2016.  Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Kalaycio ME, Kukreja M, Woolfrey AE, Szer J, Cortes J, Maziarz RT, Bolwell BJ, Buser A, Copelan E, Gale RP et al..  2010.  Allogeneic hematopoietic cell transplant for prolymphocytic leukemia.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(4):543-7. Abstract
J
Jagasia M, Arora M, Flowers MED, Chao NJ, McCarthy PL, Cutler CS, Urbano-Ispizua A, Pavletic SZ, Haagenson MD, Zhang M-J et al..  2012.  Risk factors for acute GVHD and survival after hematopoietic cell transplantation.. Blood. 119(1):296-307. Abstract
Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, Palmer J, Weisdorf D, Treister NS, Cheng G-S et al..  2015.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(3):389-401.e1. Abstract
Jacobsohn DA, Kurland BF, Pidala J, Inamoto Y, Chai X, Palmer JM, Arai S, Arora M, Jagasia M, Cutler C et al..  2012.  Correlation between NIH composite skin score, patient reported skin score and outcome: results from the Chronic GVHD Consortium.. Blood. 120(13):2545-52. Abstract
Jacobsohn DA, Arora M, Klein JP, Hassebroek A, Flowers MED, Cutler CS, Urbano-Ispizua A, Bolwell BJ, Antin JH, Boyiadzis M et al..  2011.  Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease.. Blood. 118(16):4472-9. Abstract
I
Inamoto Y, Chai X, Kurland BF, Cutler C, Flowers MED, Palmer JM, Carpenter PA, Heffernan MJ, Jacobsohn D, Jagasia MH et al..  2012.  Validation of Measurement Scales in Ocular Graft-versus-Host Disease.. Ophthalmology. 119(3):487-493. Abstract
Inamoto Y, Pidala J, Chai X, Kurland BF, Weisdorf D, Flowers MED, Palmer J, Arai S, Jacobsohn D, Cutler C et al..  2014.  Joint and fascia manifestations in chronic graft-versus-host disease and their assessment.. Arthritis and rheumatism. 66(4):1044-52. Abstract
Inamoto Y, Martin PJ, Chai X, Jagasia M, Palmer J, Pidala J, Cutler C, Pavletic SZ, Arora M, Jacobsohn D et al..  2012.  Clinical Benefit of Response in Chronic Graft-versus-Host Disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(10):1517-24. Abstract
Inamoto Y, Martin PJ, Storer BE, Palmer J, Weisdorf D, Pidala J, Flowers MED, Arora M, Jagasia M, Arai S et al..  2014.  Association of severity of organ involvement with mortality and recurrent malignancy in patients with chronic graft-versus-host disease.. Haematologica. 99(10):1618-23. Abstract
G
Griffith LM, Pavletic SZ, Lee SJ, Martin PJ, Schultz KR, Vogelsang GB.  2008.  Chronic Graft-versus-Host Disease--implementation of the National Institutes of Health Consensus Criteria for Clinical Trials.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(4):379-84.